目的探讨小切口胆总管末端结石的治疗。方法对110例胆总管末端结石患者采用小切口术中胆道镜、气囊导管等治疗的临床资料进行回顾性总结。结果术中采用胆道镜、气囊导管等清除末端结石86例（78.2%）。术后用胆道镜取出结石10例（9.1%），胆道镜联合内镜乳头括约肌切开技术清除结石14例（12.7%）。术中18例(16.4%）并发胆总管末端医源性损伤，其中1例术后并发消化道大出血死亡，其余病例经2~20年随访无远期并发症。结论胆总管末端结石采用小切口术中胆道镜、气囊导管等相结合能清除多数结石，难以取出的末端结石于术后经内镜处理为妥。
目的 了解单纯胆囊切除术患者围手术期抗菌药物的使用情况及合理性，促进临床合理用药。 方法 对昆明医学院第二附属医院2004年7～9月期间出院的661例单纯胆囊切除术患者应用抗菌药物的合理性进行回顾性分析。结果 胆囊切除患者抗菌药物应用共涉及9大类39个品种，使用率为100%。预防用药380例（57.49%），其中单用38例(10.00%)，平均用药6.55 d，平均住院时间10.79 d； 两联281例(73.95%)，平均用药6.49 d，平均住院时间12.30 d； 三联57例(15.00%)，平均用药6.52 d，平均住院时间11.75 d； 四联4例(1.05%)，平均用药6.75 d，平均住院时间9.00 d。感染治疗281例(42.51%)，其中单用10例(3.56%)，平均用药9.60 d，平均住院时间15.10 d； 两联206例(73.31%)，平均用药11.25 d，平均住院时间15.79 d； 三联56例(19.93%)，平均用药15.23 d，平均住院时间15.23 d； 四联9例(3.20%)，平均用药13.00 d，平均住院时间21.78 d。结论 单纯胆囊切除术患者抗菌药物使用存在一些不合理现象，应按围手术期给药方案进行。加强抗菌药物使用的管理和监督，不仅减少耐药菌株及不良反应的产生，而且对降低医药费用具有积极的意义。
ObjectiveTo evaluate the feasibility and surgical techniques of laparoscopic subtotal cholecystectomy （LSC) in treatment for patients with cholecystolithiasis combined with severe gallstone gallbladder inflammation, adhesion, or atrophy. MethodsThe clinical data of 83 patients with cholecystolithiasis combined with severe gallstone gallbladder inflammation, adhesion, or atrophy admitted to this hospital between January 2006 and April 2010 were analyzed retrospectively. ResultsEighty-one patients were performed LSC, 2 patients were converted to laparotomy. In which 39 patients with the part of wall residual of the fundus and (or) body of the gallbladder, 26 patients with residual of part of gallbladder neck, 18 patients with residual of part of gallbladder body and neck. Fifty-one cases were followed-up for 3 months to 4 years, there were 2 patients with the change like “mini gallbladder” by B ultrasound and no obviously clinical symptoms. There was no ostcholecystectomy syndrome in the patients with follow-up. ConclusionsLSC is a safe, effective, feasible procedure for severe gallstone gallbladder inflammation, adhesion, or atrophy, which can effectively prevent bile duct injury, bleeding, or other serious complications. While it can also reduce the rate of conversion to laparotomy.
目的 探讨胰腺结石的临床特点及诊治方法。方法 回顾性分析我院1993年5月至2011年5月期间收治的25例胰腺结石患者的临床资料。结果 本组25例中经手术及EST确诊为胰腺真性结石（胰管结石）5例，胰腺假性结石（胰实质内钙化）20例。X线、B超、CT、ERCP及MRCP诊断符合率分别为40.0%（10/25）、88.0% (22/25)、84.2%(16/19)、88.9% (8/9)和100%（2/2)。手术治疗18例，无手术死亡病例，术后患者腹痛症状均明显减轻或消失，术后3d1例发生胆漏，经充分引流治愈；非手术治疗7例，1例行EST后发生出血，经保守治疗治愈。所有患者均获随访，随访时间9个月～10年，平均5.2年，其中2例合并胰腺癌患者分别于术后9个月和11个月因肿瘤复发和转移死亡，18例手术治疗患者3年内胰管结石复发2例（11.1%），7例非手术治疗患者3年内胰管结石复发2例（28.6%），4例复发患者均经非手术治疗好转。结论 胰腺结石大多继发于慢性胰腺炎，B超为首选诊断方法；手术仍是最有效的治疗手段，手术和内镜十二指肠乳头内切开取石为主的各种治疗方法的联合应用，能提高胰腺结石的疗效。
Objective To assess the efficacy and safety of the tubeless approach with a ureteral stent versus nephrostomy tube for postoperative drainage following percutaneous nephrolithotomy, and to provide guidance for clinical practice. Methods Randomized controlled trials (RCTs) were identified from PubMed (1966 to August 2008), Ovid (1966 to August 2008), Embase (1966 to August 2008), The Cochrane Library (Issue 3, 2008) and CBM (1978 to 2008). We also handsearched for relevant published and unpublished reports and check their references. The quality of the included trials was evaluated by two reviewers. We used The Cochrane Collaboration’s RevMan 5.0.16 software for meta-analysis. Results Eight studies involving 507 patients were included. We divided the patients into three groups: small (8~9 Fr), medium (16~18 Fr) and large (20~24 Fr) according to the diameter of nephrostomy tube for the analysis. Our meta-analyses showed: ①Hospital stay (hours): There was no statistically significant difference between tubeless and small bore tubes, but a difference was found in the comparison of tubeless versus medium and large bore tubes [WMD (95%CI) –32.4 (–33.64, –31.16) and –39.07 (–67.75, –10.39), respectively]; ② Puncture site urinary leakage: No statistically significant difference was found between tubeless and small bore tubes, of between tubeless versus medium tubes [RR= 0.07, 95%CI (0.00, 1.15), P=0.06]; ③ Visual analogue scale scores for postoperative pain on Day 1: There was no statistically significant difference between tubeless and small bore tubes, but there was a difference in tubeless versus medium and large bore tubes [MD (95%CI) –2.80 (–2.94, –2.66) and –2.04 (–2.29, –1.79), respectively];④No statistically significant difference was found in transfusion, fever or infection and operating time between tubeless and any size of nephrostomy tube. Conclusion No statistically significant difference between tubeless versus small bore tubes is found for any of the outcome measurements we analysed. Compared with medium and large bore tubes, tubeless PCNL of ureteral stent could reduce hospital stay, urine leakage and postoperative pain without an increase in complications. There is a moderate possibility of selection bias, performance bias and publication bias in this review, because of the small number of the included studies, which weakens the strength of the evidence of our results. Better evidence from more high-quality randomized controlled trials is needed.
目的 探讨急诊条件下胆囊结石合并胃恶性肿瘤的诊断与治疗。方法 回顾性分析6例因胆囊结石行胆囊切除、术中意外发现胃恶性肿瘤患者的临床资料及治疗过程。结果 6例患者中5例发现胃癌，1例发现原发性胃恶性淋巴瘤。5例施行胃癌根治术，1例施行全胃切除术，无术后并发症，术后定期化疗，随访6～43个月，至术后随访截止日（2008年12月）均存活。结论 老年胆囊结石患者应注意合并胃恶性肿瘤的可能，胆囊切除术中仔细探查胃及周围器官极为重要，同时施行根治性切除是最佳选择。
Objective To study the relation between the pathogenesis of gallstone and blood lipid and protein.Methods Then indexes of blood lipid and protein in 204 cases of gallstone patients were measured and analysed by statistical software SPSS. Results There was a significant difference between the gallstone group and control in the value of proalbumin, total cholesterol, high density lipoprotein and carrier protein B (Ｐ＜0.01), the value of total protein, triglyceride, low density lipoprotein cholesterol, very low density lipoprotein cholesterol and carrier protein A1 were higher than those in the control (Ｐ＜0.05). Conclusion The indexes mentioned above may play an important role in the gallstone formation.
In 100 patients with gallstone, blood glucose, insulin were measured and BT-PAMA test, amino acid consumption test were made. Result: 71 patients were found with symptoms of the gut disorders, 12 cases with hyperglycemia (among them, 6 cases had chronic hepatic disease), 14 with exocrine pancreatic insufficiency, 26 with induration of the head of pancrease. The authors consider that hyper glycemia is correlated with chronic hepatic disease and that the gallstone migration impaires the pancreatic structure and function might be one of the factors which induces the symptom of gut disorders in patients with gallstone.